• 1
    Sweeney M H, Mocarelli P. Human health effects after exposure to 2,3,7,8-TCDD. Food Addit Contam 2000: 17: 303316.
  • 2
    Suskind R R. Chloracne, ‘‘the hallmark of dioxin intoxication’’. Scand J Work Environ Health 1985: 11: 165171.
  • 3
    Feeley M M. Biomarkers for Great Lakes priority contaminants: halogenated aromatic hydrocarbons. Environ Health Perspect 1995: 103 (Suppl. 9): 716.
  • 4
    Hambrick G W. The effect of substituted naphthalenes on the pilosebaceous apparatus of rabbit and man. J Invest Dermatol 1957: 28: 89103.
  • 5
    Crow K D. A critical review, including a comparison of two series of acne from chloronaphthalene and pitch fumes. Trans St Johns Hosp Dermatol Soc 1970: 56: 7999.
  • 6
    Cunliffe W J, Williams M, Edwards J C et al. An explanation for chloracne – an industrial hazard. Acta Derm Venereol 1975: 55: 211214.
  • 7
    Taylor J S. Environmental chloracne: update and overview. Ann N Y Acad Sci 1979: 320: 295307.
  • 8
    Dunagin W G. Cutaneous signs of systemic toxicity due to dioxins and related chemicals. J Am Acad Dermatol 1984: 10: 688700.
  • 9
    Tindall J P. Chloracne and chloracnegens. J Am Acad Dermatol 1985: 13: 539558.
  • 10
    Carlson D B, Perdew G H. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J Biochem Mol Toxicol 2002: 16: 317325.
  • 11
    Hankinson O. Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch Biochem Biophys 2005: 433: 379386.
  • 12
    Puga A, Tomlinson C R, Xia Y. Ah receptor signals cross-talk with multiple developmental pathways. Biochem Pharmacol 2005: 69: 199207.
  • 13
    Pocar P, Fischer B, Klonisch T, Hombach-Klonisch S. Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction 2005: 129: 379389.
  • 14
    Bornemann W. Ueber die histologie der chloracne. Arch Derm Res 1902: 62: 7590.
  • 15
    Herxheimer K. Uber chloracne. Munch Med Wochenschr 1899: 46: 278.
  • 16
    Hofmann H T. Neuere Erfahrungen mit hochtoxischen Chlorkohlenwasserstoffen. Arch Exp Pathol Pharmakol 1957: 232: 228230.
  • 17
    Behrbohm P. Hazards in use of chlorinated phenols. Dtsch Gesundheitsw 1959: 14: 614619.
  • 18
    Jones J W, Alden H S. An acneform dermatergosis. Arch Derm Syphilol 1936: 33: 10221034.
  • 19
    Schwartz L. Dermatitis from synthetic resins and waxes. Am J Public Health 1936: 26: 586592.
  • 20
    Schwetz B A, Norris J M, Sparschu G L et al. Toxicology of chlorinated dibenzo-p-dioxins. Environ Health Perspect 1973: 5: 8799.
  • 21
    English J S, Dawe R S, Ferguson J. Environmental effects and skin disease. Br Med Bull 2003: 68: 129142.
  • 22
    Zack J A, Suskind R R. The mortality experience of workers exposed to tetrachlorodibenzodioxin in a trichlorophenol process accident. J Occup Med 1980: 22: 1114.
  • 23
    Goldman P J. Severe acute chloracne – a mass intoxication by 2,3,6,7-tetrachlorobenzodioxin. Hautartz 1973: 24: 149152.
  • 24
    Banks Y B, Birnbaum L S. Absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) after low dose dermal exposure. Toxicol Appl Pharmacol 1991: 107: 302310.
  • 25
    Weber L W, Zesch A, Rozman K. Penetration, distribution and kinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human skin in vitro. Arch Toxicol 1991: 65: 421428.
  • 26
    Zugerman C. Chloracne. Clinical manifestations and etiology. Dermatol Clin 1990: 8: 209213.
  • 27
    Taylor J S. Chloracne – a continuing problem. Cutis 1974: 13: 585591.
  • 28
    Jensen N E. Chloracne: three cases. Proc R Soc Med 1972: 65: 687688.
  • 29
    Jensen N E, Sneddon I B, Walker A E. Tetrachlorobenzodioxin and chloracne. Trans St Johns Hosp Dermatol Soc 1972: 58: 172177.
  • 30
    Schulz K H. Clinical picture and etiology of chloracne. Arbeits Med Socialmed Arbeitshyg 1968: 3: 25.
  • 31
    Crow K D. Chloracne. Semin Dermatol 1982: 1: 305314.
  • 32
    Pastor M A, Carrasco L, Izquierdo M J et al. Chloracne: histopathologic findings in one case. J Cutan Pathol 2002: 29: 193199.
  • 33
    McDonagh A J, Gawkrodger D J, Walker A E. Chloracne – study of an outbreak with new clinical observations. Clin Exp Dermatol 1993: 18: 523525.
  • 34
    May G. Chloracne from the accidental production of tetrachlorodibenzodioxin. Br J Ind Med 1973: 30: 276283.
  • 35
    Geusau A, Jurecka W, Nahavandi H, Schmidt J B, Stingl G, Tschachler E. Punctate keratoderma-like lesions on the palms and soles in a patient with chloracne: a new clinical manifestation of dioxin intoxication? Br J Dermatol 2000: 143: 10671071.
  • 36
    Poskitt L B, Duffill M B, Rademaker M. Chloracne, palmoplantar keratoderma and localized scleroderma in a weed sprayer. Clin Exp Dermatol 1994: 19: 264267.
  • 37
    Kuratsune M, Yoshimura T, Matsuzaka J, Yamaguchi A. Yusho, a poisoning caused by rice oil contaminated with polychlorinated biphenyls. HSMHA Health Rep 1971: 86: 10831091.
  • 38
    Caputo R, Monti M, Ermacora E et al. Cutaneous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents. Follow-up 10 years after the Seveso, Italy, accident. J Am Acad Dermatol 1988: 19: 812819.
  • 39
    Crow K D. Chloracne and its potential clinical implications. Clin Exp Dermatol 1981: 6: 243257.
  • 40
    Moses M, Lilis R, Crow K D et al. Health status of workers with past exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the manufacture of 2,4,5-trichlorophenoxyacetic acid: comparison of findings with and without chloracne. Am J Ind Med 1984: 5: 161182.
  • 41
    Panteleyev A A, Roumak V S, Stepanova L V, Poznyakov S P, Bocharov B V. Clinical and ultrastructural characterization of human skin after exposure to dioxin-contaminated defoliants. Proceedings of Joint Russian–Vietnam Tropical Centre, Moscow, 1991: 300304.
  • 42
    Uenotsuchi T, Nakayama J, Asahi M et al. Dermatological manifestations in Yusho: correlation between skin symptoms and blood levels of dioxins, such as polychlorinated debenzofurans (PCDFs) and polychlorinated biphenyls (PCBs). J Dermatol Sci Suppl 2005: 1: S73S80.
  • 43
    Bauer H, Schulz K H, Spregelberg U. Occupational intoxications in manufacturing chlorophenol compounds. Arch Gewerbepathol 1961: 18: 538555.
  • 44
    Taylor J S, Wuthrich R C, Lloyd K M, Poland A. Chloracne from manufacture of a new herbicide. Arch Dermatol 1977: 113: 616619.
  • 45
    Braun W. Clinical observations on the pathogenesis of chloracne. Hautarzt 1959: 10: 126129.
  • 46
    Huff J E, Moore J A, Saracci R, Tomatis L. Long-term hazards of polychlorinated dibenzodioxins and polychlorinated dibenzofurans. Environ Health Perspect 1980: 36: 221240.
  • 47
    Thiess A M, Frentzel-Beyme R, Link R. Mortality study of persons exposed to dioxin in a trichlorophenol-process accident that occurred in the BASF AG on November 17, 1953. Am J Ind Med 1982: 3: 179189.
  • 48
    Pazderova-Vejlupkova J, Lukas E, Nemcova M, Pickova J, Jirasek L. The development and prognosis of chronic intoxication by tetrachlordibenzo-p-dioxin in men. Arch Environ Health 1981: 36: 511.
  • 49
    Jirasek L, Kalensky J, Kubec K, Pazderova J, Lukas E. Chloracne, porphyria cutanea tarda, and other poisonings due to the herbicides. Hautarzt 1976: 27: 328333.
  • 50
    Geusau A, Abraham K, Geissler K, Sator M O, Stingl G, Tschachler E. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and laboratory effects. Environ Health Perspect 2001: 109: 865869.
  • 51
    Kimbrough R D. Skin lesions in animals and humans: a brief overview. In: PolandA, KimbroughR D, eds. Banbury Report 18: Biological Mechanisms of Dioxin Action. Cold Spring Harbour: Cold Spring Harbor Laboratory, 1984: 357363.
  • 52
    Leyden J J. New understandings of the pathogenesis of acne. J Am Acad Dermatol 1995: 32: S15S25.
  • 53
    Cunliffe W J, Cotterill J A, Williamson B. Variations in skin surface lipid composition with different sampling techniques. Br J Dermatol 1971: 85: 4045.
  • 54
    Strauss J S, Pochi P E, Downing D T. Acne: perspectives. J Invest Dermatol 1974: 62: 321325.
  • 55
    Pochi P E, Strauss J S. Endocrinologic control of the development and activity of the human sebaceous gland. J Invest Dermatol 1974: 62: 191201.
  • 56
    Imperato-McGinley J, Gautier T, Cai L Q, Yee B, Epstein J, Pochi P. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab 1993: 76: 524528.
  • 57
    Sweeney M H, Calvert G M, Egeland G A, Fingerhut M A, Halperin W E, Piacitelli L A. Review and update of the results of the NIOSH medical study of workers exposed to chemicals contaminated with 2,3,7,8-tetrachlorodibenzodioxin. Teratog Carcinog Mutagen 1997: 17: 241247.
  • 58
    Johnson E, Shorter C, Bestervelt L et al. Serum hormone levels in humans with low serum concentrations of 2,3,7,8-TCDD. Toxicol Ind Health 2001: 17: 105112.
  • 59
    Simanainen U, Adamsson A, Tuomisto J T et al. Adult 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure and effects on male reproductive organs in three differentially TCDD-susceptible rat lines. Toxicol Sci 2004: 81: 401407.
  • 60
    Fukuzawa N H, Ohsako S, Wu Q et al. Testicular cytochrome P450scc and LHR as possible targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the mouse. Mol Cell Endocrinol 2004: 221: 8796.
  • 61
    Haavisto T E, Myllymaki S A, Adamsson N A et al. The effects of maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on testicular steroidogenesis in infantile male rats. Int J Androl 2006: 29: 313322.
  • 62
    Barnes-Ellerbe S, Knudsen K E, Puga A. 2,3,7,8-Tetrachlorodibenzo-p-dioxin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation. Mol Pharmacol 2004: 66: 502511.
  • 63
    Plewig G. Local treatment of chlorine acne (halowax acne) with vitamin A acid. Hautarzt 1970: 21: 465470.
  • 64
    Plewig G. Vitamin A acid therapy in chlorine acne. Which practical way can be recommended in vitamin A acid therapy of chlorine acne? Hautarzt 1971: 22: 370.
  • 65
    Shuster S. Acne: the ashes of a burnt out controversy. Acta Derm Venereol Suppl 1985: 120: 4346.
  • 66
    Gawkrodger D J. Chloracne: causation, diagnosis and treatment. J Dermatol Treat 1991: 2: 7376.
  • 67
    Scerri L, Zaki I, Millard L G. Severe halogen acne due to a trifluoromethylpyrazole derivative and its resistance to isotretinoin. Br J Dermatol 1995: 132: 144148.
  • 68
    Yip J, Peppall L, Gawkrodger D J, Cunliffe W J. Light cautery and EMLA in the treatment of chloracne lesions. Br J Dermatol 1993: 128: 313316.
  • 69
    Birnbaun LS The mechanism of dioxin toxicity: relationship to risk assessment. Environ Health Perspect 1994: 102 (Suppl. 9): 157167.
  • 70
    Geusau A, Tschachler E, Meixner M et al. Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Lancet 1999: 354: 12661267.
  • 71
    Redgrave T G, Wallace P, Jandacek R J, Tso P. Treatment with a dietary fat substitute decreased Arochlor 1254 contamination in an obese diabetic male. J Nutr Biochem 2005: 16: 383384.
  • 72
    Jandacek R J, Anderson N, Liu M, Zheng S, Yang Q, Tso P. Effects of yo-yo diet, caloric restriction, and olestra on tissue distribution of hexachlorobenzene. Am J Physiol Gastrointest Liver Physiol 2005: 288: G292G299.
  • 73
    Skene S A, Dewhurst I C, Greenberg M. Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans: the risks to human health. A review. Hum Toxicol 1989: 8: 173203.
  • 74
    Kimmig J, Shulz K H. Berufliche Akne (sog. Chlorakne) durch chlorierte aromatische zyklische Äther. Dermatologica 1957: 115: 540546.
  • 75
    Van Den Berg K J, Zurcher C, Brouwer A, Van Bekkum D W. Chronic toxicity of 3,4,3′,4′-tetrachlorobiphenyl in the marmoset monkey (Callithrix jacchus). Toxicology 1988: 48: 209224.
  • 76
    McConnell E E, Hass J R, Altman N, Moore J A. A spontaneous outbreak of polychlorinated biphenyl (PCB) toxicity in rhesus monkeys (Macaca mulatta): toxicopathology. Lab Anim Sci 1979: 29: 666673.
  • 77
    McConnell E E, Moore J A. Toxicopathology characteristics of the halogenated aromatics. Ann N Y Acad Sci 1979: 320: 138150.
  • 78
    Inagami K, Koga T, Kikuchi M, Hashimoto M, Takahashi H, Wada K. Experimental study of hairless mice following administration of rice oil used by a ‘‘Yusho’’ patient. Fukuoka Acta Med 1969: 60: 548553.
  • 79
    Hambrick G W, Blank H. A microanatomical study of the response of the pilosebaceous apparatus of the rabbit's ear canal. J Invest Dermatol 1956: 26: 185200.
  • 80
    Adams E M, Irish D D, Spencer H C, Rowe W K. The response of rabbit skin to compounds reported to have caused acneiform dermatitis. Ind Med 1941: 2: 14.
  • 81
    Jones E L, Krizek H. A technic for testing acegenic potency in rabbits, applied to the potent acnegen, 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Invest Dermatol 1962: 39: 511517.
  • 82
    Poland A, Knutson J C, Glover E. Histologic changes produced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the skin of mice carrying mutations that affect the integument. J Invest Dermatol 1984: 83: 454459.
  • 83
    Panteleyev A A, Thiel R, Wanner R et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCCD) affects keratin 1 and keratin 17 gene expression and differentially induces keratinization in hairless mouse skin. J Invest Dermatol 1997: 108: 330335.
  • 84
    Panteleyev A A, Paus R, Ahmad W, Sundberg J P, Christiano A M. Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp Dermatol 1998: 7: 249267.
  • 85
    Montagna W, Chase H B, Melaragno H P. The skin of hairless mice. 1. The formation of cysts and the distribution of lipids. J Invest Dermatol 1952: 19: 8394.
  • 86
    Panteleyev A A, Van Der Veen C, Rosenbach T, Muller-Rover S, Sokolov V E, Paus R. Towards defining the pathogenesis of the hairless phenotype. J Invest Dermatol 1998: 110: 902907.
  • 87
    Panteleyev A A, Rosenbach T, Paus R, Christiano A M. The bulge is the source of cellular renewal in the sebaceous gland of mouse skin. Arch Dermatol Res 2000: 292: 573576.
  • 88
    Puhvel S M, Sakamoto M, Ertl D C, Reisner R M. Hairless mice as models for chloracne: a study of cutaneous changes induced by topical application of established chloracnegens. Toxicol Appl Pharmacol 1982: 64: 492503.
  • 89
    Puhvel S M, Sakamoto M. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on murine skin. J Invest Dermatol 1988: 90: 354358.
  • 90
    McGowan K M, Coulombe P A. Onset of keratin 17 expression coincides with the definition of major epithelial lineages during skin development. J Cell Biol 1998: 143: 469486.
  • 91
    Panteleyev A A, Paus R, Wanner R et al. Keratin 17 gene expression during the murine hair cycle. J Invest Dermatol 1997: 108: 324329.
  • 92
    Gregory R P, Wise J C, Sikes D. Experimental production of bovine hyperkeratosis with a feed concentrate exposed to vapors of a highly chlorinated naphthalene. J Am Vet Med Assoc 1954: 125: 244246.
  • 93
    Vlahos K, McEntee K, Olafson P, Hansel W. Destruction and restoration of spermatogenesis in a bull experimentally poisoned with highly chlorinated naphthalene. Cornell Vet 1955: 45: 198209.
  • 94
    Carter C D, Kimbrough R D, Liddle J A et al. Tetrachlorodibenzodioxin: an accidental poisoning episode in horse arenas. Science 1975: 188: 738740.
  • 95
    Kimbrough R D, Carter C D, Liddle J A, Cline R E. Epidemiology and pathology of a tetrachlorodibenzodioxin poisoning episode. Arch Environ Health 1977: 32: 7786.
  • 96
    Schulz K H. Klinische und experimentelle Untersuchungen zur Ätiologie der Chlorakne. Arch Klin Exp Dermatol 1957: 206: 589596.
  • 97
    Sandermann W, Stockmann H, Casten R. Über die Pyrolise des Pentachlorphenols. Chem Ber 1957: 90: 690692.
  • 98
    Wolfe W H, Michalek J E, Miner J C et al. Health status of Air Force veterans occupationally exposed to herbicides in Vietnam. I. Physical health. JAMA 1990: 264: 18241831.
  • 99
    Westing A H, Pfeiffer E W. Dioxins in Vietnam. Science 1995: 270: 217.
  • 100
    Ramel C. Chlorinated phenoxy acids and their dioxins. Ecol Bull. Stockholm: Swedish Natural Science Research Council, 1978: 27: 302.
  • 101
    Isensee A R, Jones G E. Distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in aquatic model ecosystem. Environ Fate 1975: 9: 668672.
  • 102
    Schroy J M, Hileman F D, Cheng S C. Physical/chemical properties of 2,3,7,8-TCDD. Chemosphere 1985: 14: 877880.
  • 103
    Corsolini S, Focardi S, Kannan K, Tanabe S, Tatsukawa R. Isomer-specific analysis of polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalents (TEQs) in red fox and human adipose tissue from central Italy. Arch Environ Contam Toxicol 1995: 29: 6168.
  • 104
    Corsolini S, Kannan K, Imagawa T, Focardi S, Giesy J P. Polychloronaphthalenes and other dioxin-like compounds in Arctic and Antarctic marine food webs. Environ Sci Technol 2002: 36: 34903496.
  • 105
    Kannan K, Corsolini S, Imagawa T, Focardi S, Giesy J P. Polychlorinated-naphthalenes, -biphenyls, -dibenzo-p-dioxins, -dibenzofurans and p,p′-DDE in bluefin tuna, swordfish, cormorants and barn swallows from Italy. Ambio 2002: 31: 207211.
  • 106
    Bumb R R, Crummett W B, Cutie S S et al. Trace chemistries of fire: a source of chlorinated dioxins. Science 1980: 210: 385390.
  • 107
    Spiro T G, Thomas V M. Sources of dioxin. Science 1994: 266: 349 (author reply 350–352).
  • 108
    Czuczwa J, McVeety B, Hites R. Polychlorinated dibenzo-p-dioxins and dibenzofurans in sediments from Siskiwit Lake, Isle Royale. Science 1984: 226: 568569.
  • 109
    Czuczwa J, Niessen F, Hites R. Historical record of polychlorinated dibenzo-p-dioxins and dibenzofurans in Swiss lake sediments. Chemosphere 1985: 14: 11751179.
  • 110
    Schecter A, Papke O, Ball M, Lis A, Brandt-Rauf P. Dioxin concentrations in the blood of workers at municipal waste incinerators. Occup Environ Med 1995: 52: 385387.
  • 111
    Cohen M D, Draxler R R, Artz R et al. Modeling the atmospheric transport and deposition of PCDD/F to the Great Lakes. Environ Sci Technol 2002: 36: 48314845.
  • 112
    Hutzinger O, Choudhry G G, Chittim B G, Johnston L E. Formation of polychlorinated dibenzofurans and dioxins during combustion, electrical equipment fires and PCB incineration. Environ Health Perspect 1985: 60: 39.
  • 113
    Geyer H, Scheunert I, Korte F. Bioconcentration potential of organic environmental chemicals in humans. Regul Toxicol Pharmacol 1986: 6: 313347.
  • 114
    Travis C C, Hattemer-Frey H A. Human exposure to dioxin. Sci Total Environ 1991: 104: 97127.
  • 115
    Schecter A, Cramer P, Boggess K et al. Intake of dioxins and related compounds from food in the U.S. population. J Toxicol Environ Health A 2001: 63: 118.
  • 116
    Pirkle J L, Wolfe W H, Patterson D G et al. Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Vietnam Veterans of Operation Ranch Hand. J Toxicol Environ Health 1989: 27: 165171.
  • 117
    Wolfe W H, Michalek J E, Miner J C et al. Determinants of TCDD half-life in veterans of operation ranch hand. J Toxicol Environ Health 1994: 41: 481488.
  • 118
    EPA US. Dioxin: Summary of the Dioxin Reassessment Science. Duluth, MN: EPA US, June 12, 2000.
  • 119
    Svensson B G, Nilsson A, Hansson M, Rappe C, Akesson B, Skerfving S. Exposure to dioxins and dibenzofurans through the consumption of fish. N Engl J Med 1991: 324: 812.
  • 120
    Orban J E, Stanley J S, Schwemberger J G, Remmers J C. Dioxins and dibenzofurans in adipose tissue of the general US population and selected subpopulations. Am J Public Health 1994: 84: 439445.
  • 121
    Andrews J S, Garrett W A, Patterson D G et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin levels in adipose tissue of persons with no known exposure and in exposed persons. Chemosphere 1989: 18: 499506.
  • 122
    Koppe J G. Dioxins and furans in the mother and possible effects on the fetus and newborn breast-fed baby. Acta Paediatr Scand Suppl 1989: 360: 146153.
  • 123
    Vos J G, Kreeftenberg J G, Engel H W, Minderhoud A, Van Noorle Jansen L M. Studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin induced immune suppression and decreased resistance to infection: endotoxin hypersensitivity, serum zinc concentrations and effect of thymosin treatment. Toxicology 1978: 9: 7586.
  • 124
    Neal R A, Olson J R, Gasiewicz T A, Geiger L E. The toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mammalian systems. Drug Metab Rev 1982: 13: 355385.
  • 125
    Gupta G N, Vos J G, Moore J A, Zinkl J G, Bullock B C. Pathologic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Environ Health Perspect 1973: 15: 125140.
  • 126
    Luster M I, Faith R E, Lawson L D. Effects of 2,3,7,8-tetrachlorodibenzofuran (TCDF) on the immune system in guinea pigs. Drug Chem Toxicol 1979: 2: 4960.
  • 127
    Kimbrough R D. Determining exposure and biochemical effects in human population studies. Environ Health Perspect 1983: 48: 7779.
  • 128
    Birnbaum L S, Morrissey R E, Harris M W. Teratogenic effects of 2,3,7,8-tetrabromodibenzo-p-dioxin and three polybrominated dibenzofurans in C57BL/6N mice. Toxicol Appl Pharmacol 1991: 107: 141152.
  • 129
    Tuomisto J T, Pohjanvirta R, Unkila M, Tuomisto J. TCDD-induced anorexia and wasting syndrome in rats: effects of diet-induced obesity and nutrition. Pharmacol Biochem Behav 1999: 62: 735742.
  • 130
    Kociba R J, Keyes D G, Beyer J E et al. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 1978: 46: 279303.
  • 131
    Toth K, Somfai-Relle S, Sugar J, Bence J. Carcinogenicity testing of herbicide 2,4,5-trichlorophenoxyethanol containing dioxin and of pure dioxin in Swiss mice. Nature 1979: 278: 548549.
  • 132
    DiGiovanni J, Viaje A, Berry D L, Slaga T J, Juchau M R. Tumor-initiating ability of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and Arochlor 1254 in the two-stage system of mouse skin carcinogenesis. Bull Environ Contam Toxicol 1977: 18: 552557.
  • 133
    Poland A, Palen D, Glover E. Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature 1982: 300: 271273.
  • 134
    DeVito M J, Birnbaum L S, Farland W H, Gasiewicz T A. Comparisons of estimated human body burdens of dioxin-like chemicals and TCDD body burdens in experimentally exposed animals. Environ Health Perspect 1995: 103: 820831.
  • 135
    Goetz C G, Bolla K I, Rogers S M. Neurologic health outcomes and Agent Orange: Institute of Medicine report. Neurology 1994: 44: 801809.
  • 136
    Bertazzi P A, Bernucci I, Brambilla G, Consonni D, Pesatori A C. The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ Health Perspect 1998: 106 (Suppl. 2): 625633.
  • 137
    Mukerjee D. Health impact of polychlorinated dibenzo-p-dioxins: a critical review. J Air Waste Manag Assoc 1998: 48: 157165.
  • 138
    Stone R. Dioxin report faces scientific gauntlet. Science 1994: 265: 1650.
  • 139
    Hahn M. Aryl hydrocarbon receptors: diversity and evolution. Chem Biol Interact 2002: 141: 131160.
  • 140
    Denison M S, Nagy S R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003: 43: 309334.
  • 141
    Poland A, Glover E, Kende A S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 1976: 251: 49364946.
  • 142
    Petrulis J R, Perdew G H. The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem Biol Interact 2002: 141: 2540.
  • 143
    Perdew G H. Association of the Ah receptor with the 90-kDa heat shock protein. J Biol Chem 1988: 263: 1380213805.
  • 144
    Denis M, Cuthill S, Wikstrom A C, Poellinger L, Gustafsson J A. Association of the dioxin receptor with the Mr 90,000 heat shock protein: a structural kinship with the glucocorticoid receptor. Biochem Biophys Res Commun 1988: 155: 801807.
  • 145
    Meyer B K, Perdew G H. Characterization of the AhR–hsp90–XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization. Biochemistry 1999: 38: 89078917.
  • 146
    Kazlauskas A, Poellinger L, Pongratz I. The immunophilin-like protein XAP2 regulates ubiquitination and subcellular localization of the dioxin receptor. J Biol Chem 2000: 275: 4131741324.
  • 147
    Henry E C, Gasiewicz T A. Transformation of the aryl hydrocarbon receptor to a DNA-binding form is accompanied by release of the 90 kDa heat-shock protein and increased affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem J 1993: 294: 95101.
  • 148
    Chen H S, Perdew G H. Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. J Biol Chem 1994: 269: 2755427558.
  • 149
    Carver L A, Jackiw V, Bradfield C A. The 90-kDa heat shock protein is essential for Ah receptor signaling in a yeast expression system. J Biol Chem 1994: 269: 3010930112.
  • 150
    Cox M B, Miller C A III. The p23 co-chaperone facilitates dioxin receptor signaling in a yeast model system. Toxicol Lett 2002: 129: 1321.
  • 151
    Shetty P V, Bhagwat B Y, Chan W K. P23 enhances the formation of the aryl hydrocarbon receptor–DNA complex. Biochem Pharmacol 2003: 65: 941948.
  • 152
    Hollingshead B D, Petrulis J R, Perdew G H. The aryl hydrocarbon (Ah) receptor transcriptional regulator hepatitis B virus X-associated protein 2 antagonizes p23 binding to Ah receptor–Hsp90 complexes and is dispensable for receptor function. J Biol Chem 2004: 279: 4565245661.
  • 153
    Bradfield C A, Kende A S, Poland A. Kinetic and equilibrium studies of Ah receptor-ligand binding: use of [125I]2-iodo-7,8-dibromodibenzo-p-dioxin. Mol Pharmacol 1988: 34: 229237.
  • 154
    Swanson H I, Bradfield C A. The AH-receptor: genetics, structure and function. Pharmacogenetics 1993: 3: 213230.
  • 155
    Schmidt J V, Bradfield C A. Ah receptor signaling pathways. Annu Rev Cell Dev Biol 1996: 12: 5589.
  • 156
    Elferink C J, Whitlock J P Jr. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-inducible, Ah receptor-mediated bending of enhancer DNA. J Biol Chem 1990: 265: 57185721.
  • 157
    Mimura J, Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 2003: 1619: 263268.
  • 158
    Poland A, Knutson J C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 1982: 22: 517554.
  • 159
    Fernandez-Salguero P, Pineau T, Hilbert D M et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995: 268: 722726.
  • 160
    Schmidt J V, Su G H, Reddy J K, Simon M C, Bradfield C A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci U S A 1996: 93: 67316736.
  • 161
    Fernandez-Salguero P M, Hilbert D M, Rudikoff S, Ward J M, Gonzalez F J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 1996: 140: 173179.
  • 162
    Lin T M, Ko K, Moore R W, Buchanan D L, Cooke P S, Peterson R E. Role of the aryl hydrocarbon receptor in the development of control and 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed male mice. J Toxicol Environ Health A 2001: 64: 327342.
  • 163
    Hoffer A, Chang C Y, Puga A. Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways. Toxicol Appl Pharmacol 1996: 141: 238247.
  • 164
    Fernandez-Salguero P M, Ward J M, Sundberg J P, Gonzalez F J. Lesions of aryl-hydrocarbon receptor-deficient mice. Vet Pathol 1997: 34: 605614.
  • 165
    Lahvis G P, Lindell S L, Thomas R S et al. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci U S A 2000: 97: 1044210447.
  • 166
    Wanner R, Panteleyev A, Henz B M, Rosenbach T. Retinoic acid affects the expression rate of the differentiation-related genes aryl hydrocarbon receptor, ARNT and keratin 4 in proliferative keratinocytes only. Biochim Biophys Acta 1996: 1317: 105111.
  • 167
    Okey A B, Vella L M, Harper P A. Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene. Mol Pharmacol 1989: 35: 823830.
  • 168
    Harper P A, Wong J Y, Lam M S, Okey A B. Polymorphisms in the human AH receptor. Chem Biol Interact 2002: 141: 161187.
  • 169
    Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 1995: 35: 307340.
  • 170
    Dunlap D Y, Ikeda I, Nagashima H, Vogel C F, Matsumura F. Effects of src-deficiency on the expression of in vivo toxicity of TCDD in a strain of c-src knockout mice procured through six generations of backcrossings to C57BL/6 mice. Toxicology 2002: 172: 125141.
  • 171
    Madhukar B V, Brewster D W, Matsumura F. Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster. Proc Natl Acad Sci U S A 1984: 81: 74077411.
  • 172
    Matsumura F. How important is the protein phosphorylation pathway in the toxic expression of dioxin-type chemicals? Biochem Pharmacol 1994: 48: 215224.
  • 173
    Kohn M C. Biochemical mechanisms and cancer risk assessment models for dioxin. Toxicology 1995: 102: 133138.
  • 174
    Bombick D W, Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes elevation of the levels of the protein tyrosine kinase pp60c-src. J Biochem Toxicol 1987: 2: 141154.
  • 175
    Sewall C H, Clark G C, Lucier G W. TCDD reduces rat hepatic epidermal growth factor receptor: comparison of binding, immunodetection, and autophosphorylation. Toxicol Appl Pharmacol 1995: 132: 263272.
  • 176
    Bryant P L, Clark G C, Probst M R, Abbott B D. Effects of TCDD on Ah receptor, ARNT, EGF, and TGF-alpha expression in embryonic mouse urinary tract. Teratology 1997: 55: 326337.
  • 177
    Enan E, Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem Pharmacol 1996: 52: 15991612.
  • 178
    Cooper J A. Oncogenes and anti-oncogenes. Curr Opin Cell Biol 1990: 2: 285295.
  • 179
    Herschman H R. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 1991: 60: 281319.
  • 180
    Dong L, Ma Q, Whitlock J P Jr. Down-regulation of major histocompatibility complex Q1b gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 1997: 272: 2961429619.
  • 181
    Ishida S, Jinno H, Tanaka-Kagawa T et al. Characterization of human CYP1A1/1A2 induction by DNA microarray and alpha-naphthoflavone. Biochem Biophys Res Commun 2002: 296: 172177.
  • 182
    Prough R A. Introduction: basal and inducible expression of cytochromes P450 and related enzymes. FASEB J 1996: 10: 807808.
  • 183
    Nebert D W, Dalton T P, Okey A B, Gonzalez F J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 2004: 279: 2384723850.
  • 184
    Sutter T R, Guzman K, Dold K M, Greenlee W F. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science 1991: 254: 415418.
  • 185
    Gaido K W, Maness S C. Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 1994: 127: 199208.
  • 186
    Choi E J, Toscano D G, Ryan J A, Riedel N, Toscano W A Jr. Dioxin induces transforming growth factor-alpha in human keratinocytes. J Biol Chem 1991: 266: 95919597.
  • 187
    Dohr O, Vogel C, Abel J. Modulation of growth factor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Exp Clin Immunogenet 1994: 11: 142148.
  • 188
    Madhukar B V, Ebner K, Matsumura F, Bombick D W, Brewster D W, Kawamoto T. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an increase in protein kinases associated with epidermal growth factor receptor in the hepatic plasma membrane. J Biochem Toxicol 1988: 3: 261277.
  • 189
    Couture L A, Abbott B D, Birnbaum L S. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism. Teratology 1990: 42: 619627.
  • 190
    Abbott B D, Birnbaum L S. TCDD alters medial epithelial cell differentiation during palatogenesis. Toxicol Appl Pharmacol 1989: 99: 276286.
  • 191
    Gaido K W, Maness S C, Leonard L S, Greenlee W F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and -beta 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J Biol Chem 1992: 267: 2459124595.
  • 192
    Karyala S, Guo J, Sartor M et al. Different global gene expression profiles in benzo[a]pyrene- and dioxin-treated vascular smooth muscle cells of AHR-knockout and wild-type mice. Cardiovasc Toxicol 2004: 4: 4773.
  • 193
    Abbott B D, Birnbaum L S. TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicol Appl Pharmacol 1990: 106: 418432.
  • 194
    Barker C W, Fagan J B, Pasco D S. Interleukin-1 beta suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J Biol Chem 1992: 267: 80508055.
  • 195
    Gasiewicz T A, Neal R A. 2,3,7,8-Tetrachlorodibenzo-p-dioxin tissue distribution, excretion, and effects on clinical chemical parameters in guinea pigs. Toxicol Appl Pharmacol 1979: 51: 329339.
  • 196
    Brewster D W, Matsumura F. Differential effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on adipose tissue lipoprotein lipase activity in the guinea pig, rat, hamster, rabbit, and mink. Comp Biochem Physiol C 1989: 93: 4953.
  • 197
    Clark G C, Taylor M J, Tritscher A M, Lucier G W. Tumor necrosis factor involvement in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated endotoxin hypersensitivity in C57BL/6J mice congenic at the Ah locus. Toxicol Appl Pharmacol 1991: 111: 422431.
  • 198
    Taylor M J, Lucier G W, Mahler J F, Thompson M, Lockhart A C, Clark G C. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol Appl Pharmacol 1992: 117: 126132.
  • 199
    Kolluri S K, Weiss C, Koff A, Gottlicher M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 1999: 13: 17421753.
  • 200
    Matikainen T, Perez G I, Jurisicova A et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 2001: 28: 355360.
  • 201
    Zeytun A, McKallip R J, Fisher M, Camacho I, Nagarkatti M, Nagarkatti P S. Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays. Toxicology 2002: 178: 241260.
  • 202
    Hurst C H, Abbott B, Schmid J E, Birnbaum L S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) disrupts early morphogenetic events that form the lower reproductive tract in female rat fetuses. Toxicol Sci 2002: 65: 8798.
  • 203
    Ohbayashi T, Oikawa K, Iwata R et al. Dioxin induces a novel nuclear factor, DIF-3, that is implicated in spermatogenesis. FEBS Lett 2001: 508: 341344.
  • 204
    Knutson J C, Poland A. Keratinization of mouse teratoma cell line XB produced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: an in vitro model of toxicity. Cell 1980: 22: 2736.
  • 205
    Greenlee W F, Dold K M, Osborne R. Actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human epidermal keratinocytes in culture. In Vitro Cell Dev Biol 1985: 21: 509512.
  • 206
    Hudson L G, Toscano W A Jr, Greenlee W F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF) binding to basal cells from a human keratinocyte cell line. Toxicol Appl Pharmacol 1986: 82: 481492.
  • 207
    Milstone L M, LaVigne J F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces hyperplasia in confluent cultures of human keratinocytes. J Invest Dermatol 1984: 82: 532534.
  • 208
    Osborne R, Greenlee W F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances terminal differentiation of cultured human epidermal cells. Toxicol Appl Pharmacol 1985: 77: 434443.
  • 209
    Puhvel S M, Sakamoto M. Response of murine epidermal keratinocyte cultures to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): comparison of haired and hairless genotypes. Toxicol Appl Pharmacol 1987: 89: 2936.
  • 210
    Loertscher J A, Sattler C A, Allen-Hoffmann B L. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation pattern of human keratinocytes in organotypic culture. Toxicol Appl Pharmacol 2001: 175: 121129.
  • 211
    Smola H, Thiekotter G, Fusenig N E. Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 1993: 122: 417429.
  • 212
    Maas-Szabowski N, Szabowski A, Stark H J et al. Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation. J Invest Dermatol 2001: 116: 816820.
  • 213
    Botchkarev V A, Kishimoto J. Molecular control of epithelial–mesenchymal interactions during hair follicle cycling. J Investig Dermatol Symp Proc 2003: 8: 4655.
  • 214
    Rendl M, Lewis L, Fuchs E. Molecular dissection of mesenchymal–epithelial interactions in the hair follicle. PLoS Biol 2005: 3: e331.
  • 215
    Sadek C M, Allen-Hoffmann B L. Cytochrome P450IA1 is rapidly induced in normal human keratinocytes in the absence of xenobiotics. J Biol Chem 1994: 269: 1606716074.
  • 216
    Poland A, Glover E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin: segregation of toxicity with the Ah locus. Mol Pharmacol 1980: 17: 8694.
  • 217
    Vogel C F, Matsumura F. Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) with induced adipocyte differentiation in mouse embryonic fibroblasts (MEFs) involves tyrosine kinase c-Src. Biochem Pharmacol 2003: 66: 12311244.
  • 218
    Schiller C M, Adcock C M, Moore R A, Walden R. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and fasting on body weight and lipid parameters in rats. Toxicol Appl Pharmacol 1985: 81: 356361.
  • 219
    Pelclova D, Fenclova Z, Preiss J et al. Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8-tetrachlordibenzo-p-dioxin. Int Arch Occup Environ Health 2002: 75 (Suppl.): S60S66.
  • 220
    Loertscher J A, Lin T M, Peterson R E, Allen-Hoffmann B L. In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin causes accelerated terminal differentiation in fetal mouse skin. Toxicol Sci 2002: 68: 465472.
  • 221
    Tauchi M, Hida A, Negishi T et al. Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol Cell Biol 2005: 25: 93609368.
  • 222
    Arnold I, Watt F M. c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr Biol 2001: 11: 558568.
  • 223
    Waikel R L, Kawachi Y, Waikel P A, Wang X J, Roop D R. Deregulated expression of c-Myc depletes epidermal stem cells. Nat Genet 2001: 28: 165168.
  • 224
    Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W. beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 2001: 105: 533545.
  • 225
    Panteleyev A A, Thiel R, Rosenbach T, Christiano A M. Acne chlorina and acne vulgaris – casual likeness or casual homology? Arch Dermatol Res 2000: 292: 577581.
  • 226
    Cotsarelis G, Kaur P, Dhouailly D, Hengge U, Bickenbach J. Epithelial stem cells in the skin: definition, markers, localization and functions. Exp Dermatol 1999: 8: 8088.
  • 227
    Fuchs E. Beauty is skin deep: the fascinating biology of the epidermis and its appendages. Harvey Lect 1998: 94: 4777.
  • 228
    Taylor G, Lehrer M S, Jensen P J, Sun T T, Lavker R M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 2000: 102: 451461.
  • 229
    Panteleyev A A, Jahoda C A, Christiano A M. Hair follicle predetermination. J Cell Sci 2001: 114: 34193431.
  • 230
    Murante F G, Gasiewicz T A. Hemopoietic progenitor cells are sensitive targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J mice. Toxicol Sci 2000: 54: 374383.
  • 231
    Fine J S, Silverstone A E, Gasiewicz T A. Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol 1990: 144: 11691176.
  • 232
    Silverstone A E, Frazier D E Jr, Gasiewicz T A. Alternate immune system targets for TCDD: lymphocyte stem cells and extrathymic T-cell development. Exp Clin Immunogenet 1994: 11: 94101.
  • 233
    Knutson J C, Poland A. Response of murine epidermis to 2,3,7,8-tetrachlorodibenzo-p-dioxin: interaction of the ah and hr loci. Cell 1982: 30: 225234.
  • 234
    Gu Y Z, Hogenesch J B, Bradfield C A. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 2000: 40: 519561.
  • 235
    Xu C, Li C Y, Kong A N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 2005: 28: 249268.
  • 236
    Hombach-Klonisch S, Pocar P, Kietz S, Klonisch T. Molecular actions of polyhalogenated arylhydrocarbons (PAHs) in female reproduction. Curr Med Chem 2005: 12: 599616.
  • 237
    Takagi S, Tojo H, Tomita S et al. Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function. J Clin Invest 2003: 112: 13721382.
  • 238
    Tomita S, Jiang H B, Ueno T et al. T cell-specific disruption of arylhydrocarbon receptor nuclear translocator (Arnt) gene causes resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced thymic involution. J Immunol 2003: 171: 41134120.
  • 239
    Tomita S, Sinal C J, Yim S H, Gonzalez F J. Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha. Mol Endocrinol 2000: 14: 16741681.
  • 240
    Jones C L, Reiners J J Jr. Differentiation status of cultured murine keratinocytes modulates induction of genes responsive to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Biochem Biophys 1997: 347: 163173.
  • 241
    Jensen P J, Yang T, Yu D W et al. Serpins in the human hair follicle. J Invest Dermatol 2000: 114: 917922.
  • 242
    Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000: 19: 25482556.
  • 243
    Ray S S, Swanson H I. Alteration of keratinocyte differentiation and senescence by the tumor promoter dioxin. Toxicol Appl Pharmacol 2003: 192: 131145.
  • 244
    Murphy K A, Villano C M, Dorn R, White L A. Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes. J Biol Chem 2004: 279: 2528425293.
  • 245
    Mimeault M, Bonenfant D, Batra S K. New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers. Skin Pharmacol Physiol 2004: 17: 153166.
  • 246
    Oshima H, Rochat A, Kedzia C, Kobayashi K, Barrandon Y. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell 2001: 104: 233245.
  • 247
    Cotsarelis G, Sun T T, Lavker R M. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990: 61: 13291337.
  • 248
    Morris R J, Potten C S. Slowly cycling (label-retaining) epidermal cells behave like clonogenic stem cells in vitro. Cell Prolif 1994: 27: 279289.
  • 249
    Morris R J, Potten C S. Highly persistent label-retaining cells in the hair follicles of mice and their fate following induction of anagen. J Invest Dermatol 1999: 112: 470475.
  • 250
    Honeycutt K A, Roop D R. c-Myc and epidermal stem cell fate determination. J Dermatol 2004: 31: 368375.
  • 251
    Chen C R, Kang Y, Siegel P M, Massague J. E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 2002: 110: 1932.
  • 252
    Pelengaris S, Khan M. The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin Ther Targets 2003: 7: 623642.
  • 253
    Schrenk D, Muller M, Merlino G, Thorgeirsson S S. Interactions of TCDD with signal transduction and neoplastic development in c-myc transgenic and TGF-alpha transgenic mice. Arch Toxicol Suppl 1997: 19: 367375.
  • 254
    Ashida H, Nagy S, Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced changes in activities of nuclear protein kinases and phosphatases affecting DNA binding activity of c-Myc and AP-1 in the livers of guinea pigs. Biochem Pharmacol 2000: 59: 741751.
  • 255
    Nagashima H, Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced down-regulation of glucose transporting activities in mouse 3T3-L1 preadipocyte. J Environ Sci Health B 2002: 37: 114.
  • 256
    Merrill B J, Gat U, DasGupta R, Fuchs E. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev 2001: 15: 16881705.
  • 257
    Li Y, Kuwahara H, Ren J, Wen G, Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J Biol Chem 2001: 276: 60616064.
  • 258
    Morin P J. beta-Catenin signaling and cancer. Bioessays 1999: 21: 10211030.
  • 259
    Behrens J. Control of beta-catenin signaling in tumor development. Ann N Y Acad Sci 2000: 910: 2133.
  • 260
    Smalley M J, Dale T C. Wnt signaling and mammary tumorigenesis. J Mammary Gland Biol Neoplasia 2001: 6: 3752.
  • 261
    Wang Y H, Li F, Schwartz J H, Flint P J, Borkan S C. c-Src and HSP72 interact in ATP-depleted renal epithelial cells. Am J Physiol Cell Physiol 2001: 281: C1667C1675.
  • 262
    Blanpain C, Lowry W E, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 2004: 118: 635648.
  • 263
    Watt F M. Epidermal stem cells: markers, patterning and the control of stem cell fate. Philos Trans R Soc Lond B Biol Sci 1998: 353: 831837.
  • 264
    EPA US. Interim Report on Data and Methods for Assessment of 2,3,7,8-Tetrachlorodibenzo-p-dioxin Risk to Aquatic Life and Associated Wildlife. Duluth, MN: EPA US, March 1993: 1159.
  • 265
    Waikel R L, Kawachi Y, Waikel P A, Wang X J, Roop D R. Deregulated expression of c-Myc depletes epidermal stem cells. Nat Genet 2001: 28: 165168.